{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:51:10Z","timestamp":1792511470315,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jvacx.2023.100339","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T03:52:14Z","timestamp":1687924334000},"page":"100339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Infant vaccination against pertussis in Argentina: Parent-reported outcomes on reactogenicity, impact on daily routine and satisfaction after pentavalent whole-cell or hexavalent acellular pertussis vaccines"],"prefix":"10.1016","volume":"14","author":[{"given":"Angela","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa Edelvais","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabella","family":"Pacchiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela","family":"del Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda Romero","family":"Boll\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Lieste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Deluca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Vargas-Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jvacx.2023.100339_b0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/oxfordjournals.epirev.a017931","article-title":"Epidemiologic methods in immunization programs","volume":"18","author":"Chen","year":"1996","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.jvacx.2023.100339_b0010","unstructured":"Argentine Ministry of Health. Immune Preventable Diseases Control Direction. National Immunization Program. Available at: https:\/\/www.argentina.gob.ar\/salud\/vacunas (Accessed August 2022)."},{"key":"10.1016\/j.jvacx.2023.100339_b0015","unstructured":"Pertussis vaccines: WHO position paper - September 2015. Wkly Epidemiol Rec 2015; 90(35): 433\u2013458."},{"key":"10.1016\/j.jvacx.2023.100339_b0020","unstructured":"ANMAT (Federal Food, Drug, and Medical Technology Administration) Available at: https:\/\/servicios.pami.org.ar\/vademecum\/views\/consultaPublica\/listado.zul."},{"issue":"1","key":"10.1016\/j.jvacx.2023.100339_b0025","first-page":"45","article-title":"Analysis of adverse events following immunization in Minas Gerais, Brazil, 2011: a cross-sectional study","volume":"25","author":"Silva","year":"2016","journal-title":"Epidemiol Serv Saude"},{"issue":"3","key":"10.1016\/j.jvacx.2023.100339_b0030","first-page":"325","article-title":"Caracterizaci\u00f3n de eventos adversos asociados a vacunas que inmunizan contra enfermedades infecciosas: a\u00f1os 2006\u20132007","volume":"44","author":"Mato","year":"2010","journal-title":"Rev Cuba Farm Jul-Sept"},{"key":"10.1016\/j.jvacx.2023.100339_b0035","unstructured":"WHO Information Sheet: Observed rate of vaccine reactions \u2013 Diphtheria, pertussis, tetanus vaccines, May 2014. Available at: https:\/\/www.who.int\/publications\/m\/item\/DTP-vaccine-rates-information-sheet (accessed September 2022)."},{"key":"10.1016\/j.jvacx.2023.100339_b0040","doi-asserted-by":"crossref","unstructured":"Zhang L, Prietsch SO, Axelsson I, Halperin SA. Acellular vaccines for preventing whooping cough in children.Cochrane Database Syst Rev. 2014;(9):CD001478. Published 2014 Sep 17. doi:10.1002\/14651858.CD001478.pub6.","DOI":"10.1002\/14651858.CD001478.pub6"},{"key":"10.1016\/j.jvacx.2023.100339_b0045","doi-asserted-by":"crossref","unstructured":"Patterson J, Kagina BM, Gold M, Hussey GD, Muloiwa R. Comparison of adverse events following immunization with acellular and whole-cell pertussis vaccines: A systematic review.Vaccine. 2018;36(40):6007-6016. doi:10.1016\/j.vaccine.2018.08.022.","DOI":"10.1016\/j.vaccine.2018.08.022"},{"key":"10.1016\/j.jvacx.2023.100339_b0050","unstructured":"National Program for the Control of Immune Preventable Diseases. Safe vaccination. Surveillance of events supposedly attributable to vaccination or immunization (ESAVI). Technical Guidelines. Argentina 2012. Available at: https:\/\/www.argentina.gob.ar\/salud\/inmunoprevenibles\/recomendaciones-manuales-y-lineamientos (Accessed September 2022)."},{"key":"10.1016\/j.jvacx.2023.100339_b0055","unstructured":"Research Electronic Data Capture (REDCap). Available on: https:\/\/www.project-redcap.org\/."},{"issue":"43","key":"10.1016\/j.jvacx.2023.100339_b0060","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1016\/j.vaccine.2020.08.046","article-title":"Parent reported outcomes to measure satisfaction, acceptability, and daily life impact after vaccination with whole-cell and acellular pertussis vaccine in Chile","volume":"38","author":"O'Ryan","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2023.100339_b0065","doi-asserted-by":"crossref","unstructured":"Le Saux, N., Barrowman, N. J., Moore, D. L., Whiting, S., Scheifele, D., Halperin, S., & Canadian Paediatric Society\/ Health Canada Immunization Monitoring Program-Active (IMPACT) (2003). Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.Pediatrics,112(5), e348. https:\/\/doi.org\/10.1542\/peds.112.5.","DOI":"10.1542\/peds.112.5.e348"},{"key":"10.1016\/j.jvacx.2023.100339_b0070","doi-asserted-by":"crossref","unstructured":"Mac\u00edas, M., Lanata, C. F., Zambrano, B., Gil, A. I., Amemiya, I., Mispireta, et al. (2012). Safety and immunogenicity of an investigational fully liquid hexavalent DTaP-IPV-Hep B-PRP-T vaccine at two, four and six months of age compared with licensed vaccines in Latin America.The Pediatric infectious disease journal,31(8), e126\u2013e132. https:\/\/doi.org\/10.1097\/INF.","DOI":"10.1097\/INF.0b013e318258400d"},{"issue":"6","key":"10.1016\/j.jvacx.2023.100339_b0075","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1097\/INF.0b013e318212eb80","article-title":"Immunogenicity and safety of an investigational hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae B conjugate combined vaccine in healthy 2-, 4-, and 6-month-old Argentinean infants","volume":"30","author":"Tregnaghi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.jvacx.2023.100339_b0080","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/INF.0000000000002109","article-title":"Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic","volume":"37","author":"Prymula","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.jvacx.2023.100339_b0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-019-1147-4","article-title":"Usability of daily SF36 questionnaires to capture the QALD variation experienced after vaccination with AS03A-adjuvanted monovalent influenza A (H5N1) vaccine in a safety and tolerability study","volume":"17","author":"Standaert","year":"2019","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"10.1016\/j.jvacx.2023.100339_b0090","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1080\/21645515.2015.1044180","article-title":"The value of childhood combination vaccines: From beliefs to evidence","volume":"11","author":"Maman","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jvacx.2023.100339_b0095","first-page":"100187","article-title":"Long-term antibody response following SPUTNIK V primary vaccination in healthcare workers with and without history of SARS-CoV-2 infection: Prospective cohort study from a hospital in Argentina","volume":"11","author":"Gentile","year":"2022","journal-title":"Vaccine: X"},{"issue":"10255","key":"10.1016\/j.jvacx.2023.100339_b0100","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(20)31558-0","article-title":"Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study","volume":"396","author":"de Figueiredo","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jvacx.2023.100339_b0105","unstructured":"Salud P\u00fablica. Ley 27491. Control de enfermedades prevenibles por vacunaci\u00f3n. Available at: https:\/\/www.argentina.gob.ar\/normativa\/nacional\/ley-27491-318455 (Accessed October 2022)."},{"key":"10.1016\/j.jvacx.2023.100339_b0110","unstructured":"Argentine Ministry of Health. Immune Preventable Diseases Control Direction. Report on the impact of the SARS-CoV-2 pandemic on national vaccination coverage in Argentina. December 2021 Available at: https:\/\/bancos.salud.gob.ar\/recurso\/informe-sobre-el-impacto-de-la-pandemia-sars-cov-2-en-las-coberturas-nacionales-de (Accessed September 2022)."},{"issue":"3\/4","key":"10.1016\/j.jvacx.2023.100339_b0115","first-page":"93","article-title":"Social stratification and human biology: Graffar\u2019s modified method","volume":"49","author":"M\u00e9ndez Castellano","year":"1986","journal-title":"Arch venez pueric pediatr"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136223000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:27:48Z","timestamp":1792510068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136223000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":23,"alternative-id":["S2590136223000803"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100339","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infant vaccination against pertussis in Argentina: Parent-reported outcomes on reactogenicity, impact on daily routine and satisfaction after pentavalent whole-cell or hexavalent acellular pertussis vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2023.100339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100339"}}